Oral sleeping sickness drug, fexinidazole, approved by European agency
by Press Release from Outbreak News Today on (#438HM)
The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive scientific opinion of fexinidazole, the first all-oral treatment that has been shown to be efficacious for both stages of sleeping sickness. This approval is a result of clinical trials led by the non-profit research and development organization DNDi and ["]
The post Oral sleeping sickness drug, fexinidazole, approved by European agency appeared first on Outbreak News Today.